Latest News

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

The nCino, Inc. ( NASDAQ:NCNO ) share price has fared very poorly over the last month, falling by a substantial 33...

Allegion plc's ( NYSE:ALLE ) periodic dividend will be increasing on the 31st of March to $0.55, with investors...

Apollo Global Management, Inc. ( NYSE:APO ) is about to trade ex-dividend in the next 2 days. The ex-dividend date is...

Bendigo and Adelaide Bank (ASX:BEN) has put a mixed set of numbers on the table for H1 2026, with trailing twelve month revenue at A$1.98b and basic EPS at a loss of A$0.15 per share, alongside trailing net income excluding extra items of A$83.3 million in losses. Over recent periods the bank has seen revenue hold around the A$1.9b mark on a trailing basis, while basic EPS has shifted from A$0.85 per share in H1 2025 to a loss of A$0.17 per share by H2 2025, before landing at the current...

Wondering whether Alvotech at US$4.64 is a potential bargain or a value trap? This article will walk you through what the current price might be implying about the company. The stock has had a tough run, with a 9.7% decline over the last week, 5.7% over the last month and 7.2% year to date, while the 1 year return sits at a 64.3% loss. Recent trading has been shaped by ongoing investor reaction to Alvotech's progress and risks in the biosimilars space, as the market weighs its prospects...

In February 2026, Regal Rexnord reported that fourth-quarter 2025 sales rose to US$1,523.2 million while net income increased to US$63.5 million, with full-year 2025 net income improving to US$279.5 million on slightly lower annual sales of US$5,934.5 million. The company also issued full-year 2026 GAAP diluted EPS guidance of US$5.29 to US$6.09, highlighting management’s confidence after year-over-year earnings growth despite softer annual revenue. With management now guiding 2026 GAAP...

How Walmart (WMT) looks after its recent share performance Recent share price moves have put Walmart (WMT) back on many investors’ screens, with the stock showing positive returns over the past week, month and past 3 months. Here is how the fundamentals compare. See our latest analysis for Walmart. At a share price of US$133.89, Walmart’s recent 30 day share price return of 11.85% and 90 day return of 32.05% point to strong momentum. The 1 year total shareholder return of 29.92%, along with...

Why the latest earnings matter for Fuyo General Lease Fuyo General Lease (TSE:8424) released nine month results to December 31, 2025, with sales of ¥590,436 million compared with ¥481,761 million a year earlier, while net income and earnings per share were significantly lower. See our latest analysis for Fuyo General Lease. The latest nine month earnings sit against a share price of ¥4,552 and a 90 day share price return of 13.66%, while the 1 year total shareholder return of 26.27% and 5...

Technology One (ASX:TNE) has come under pressure after a sharp sell off in the ASX Information Technology sector, with technical scans flagging the stock in a downtrend and drawing fresh attention from investors. See our latest analysis for Technology One. At around A$21.30, Technology One’s recent 30 day share price return of 21.86% and year to date share price return of 23.55% decline, alongside a 1 year total shareholder return of 32.73% decline, point to fading momentum despite a 5 year...

If you are wondering whether UiPath is starting to look interesting at current levels, this article will walk through what the recent share price and fundamentals might be telling you about its value. UiPath shares last closed at US$11.32, with returns of 12.9% decline over 7 days, 21.1% decline over 30 days, 28.7% decline year to date, 24.2% decline over 1 year and 27.2% decline over 3 years, which may have shifted how the market is thinking about its risk and potential. Recent headlines...

Abbott Laboratories (ABT) is under fresh legal scrutiny after a wrongful death lawsuit linked alleged defects in its FreeStyle Libre 3 glucose monitors to multiple deaths and serious injuries, drawing investor attention to product safety risk. See our latest analysis for Abbott Laboratories. At a share price of $112.68, Abbott’s recent 1 day and 7 day share price returns of 1.09% and 1.45% sit against a 30 day share price return decline of 7.46% and a 90 day share price return decline of...

GWA Group (ASX:GWA) has put fresh numbers on the table for H1 2026, with revenue of A$208.6 million, basic EPS of A$0.083 and net income of A$21.8 million framing the latest half. The company has seen revenue move from A$207.5 million in H2 2024 to A$209.9 million in H1 2025 and A$208.6 million in H2 2025, while basic EPS has shifted from A$0.058 to A$0.081 and A$0.083 over the same periods. This sets up this result against a backdrop of improving trailing margins and a richer profit pool...

Audinate Group (ASX:AD8) H1 2026 earnings snapshot Audinate Group (ASX:AD8) has reported its H1 2026 numbers with total revenue of A$33.3 million and a basic EPS loss of A$0.05, while trailing twelve month figures show revenue of A$65.5 million and a basic EPS loss of A$0.18. The company has seen revenue move from A$44.9 million in H2 2024 to A$28.7 million in H1 2025 and A$33.3 million in H2 2025, alongside a shift from basic EPS of A$0.07 to losses of A$0.03 and A$0.05. This sets up a...

Why ADT’s index additions matter for investors ADT (ADT) has just been added to the S&P 600, S&P 1000, S&P Composite 1500, and the S&P 600 Consumer Discretionary index, a shift that can influence trading interest and liquidity. See our latest analysis for ADT. ADT’s recent index additions come after a period where short term share price returns have been soft, with a 7 day share price return decline of 4.56% and a 30 day share price return decline of 6.18%. Meanwhile, the 1 year total...

Boston Scientific (BSX) is back in focus after Q4 2025 adjusted earnings came in above consensus. However, investor attention has shifted to signs of stagnation in the company’s U.S. electrophysiology business. See our latest analysis for Boston Scientific. The share price has retreated sharply in recent months, with a 30 day share price return of 15.15% and a 90 day share price return of 24.68%, even though the 3 year total shareholder return sits at 60.57% and the 5 year total shareholder...

Why International Petroleum’s latest earnings and guidance matter for investors International Petroleum (TSX:IPCO) recently paired its full year 2025 earnings release with fresh 2026 production guidance. This gives investors a combined look at recent financial results and management’s expectations for upcoming output. The company reported 2025 sales of US$681.5 million and net income of US$28.94 million, alongside a forecast for 2026 average net production between 44,000 and 47,000 barrels of...

Agios Pharmaceuticals reported full-year 2025 results, with revenue rising to US$54.03 million from US$36.5 million, while swinging from net income of US$673.73 million to a very large net loss of US$412.78 million and filing an omnibus mixed-shelf registration covering equity, debt, warrants, and units. Despite the sharp earnings reversal, investors are focusing on stronger-than-expected quarterly performance, growing contributions from PYRUKYND® and newly launched AQVESME™, and the added...

Shopify (NasdaqGS:SHOP) has authorized a $2b share repurchase program, signaling management's focus on returning capital to shareholders. The company is rolling out new AI tools, including Sidekick and its Universal Commerce Protocol, to deepen AI-driven support for merchants. These moves come as Shopify highlights strong growth in its commerce platform and the expanding role of AI in merchant workflows. Shopify, trading at around $112.70, has seen mixed share performance recently, with a 7...

If you are wondering whether Occidental Petroleum's current share price really reflects its underlying value, you are not alone. This article is designed to help you weigh what you are paying against what you are getting. The stock last closed at US$46.07, with recent returns of a 1.3% decline over 7 days, 7.9% over 30 days, 8.7% year to date, a 2.0% decline over 1 year, a 20.3% decline over 3 years, and 84.7% over 5 years. Taken together, this gives you a mixed picture of how the market has...

Earlier this month, HP Inc. amended its bylaws and announced that long-time CEO Enrique Lores stepped down, with board member Bruce Broussard becoming interim CEO while the board conducts a formal search for a permanent successor. At the same time, HP reaffirmed its first-quarter and full-year 2026 earnings guidance and outlined measures to manage higher memory costs and softer demand in PCs and printing, underscoring both continuity and pressure in its operating backdrop. We’ll now examine...

Aktieselskabet Schouw & Co. (CPSE:SCHO) shareholders approved the release of BioMar as an Original Guarantor under the company’s bond terms. The decision removes BioMar from its status as a Material Subsidiary in the bond documentation. The approval was granted by a majority vote of shareholders. Aktieselskabet Schouw & Co. (CPSE:SCHO) is a Danish industrial group with holdings across several sectors, and BioMar has been one of its key subsidiaries. The shareholder-backed decision to remove...

Fastly (FSLY) is back in focus after reporting record fourth quarter results, returning to an adjusted profit and issuing full year 2026 revenue guidance that came in well above earlier analyst expectations. See our latest analysis for Fastly. The latest results have triggered a sharp re-rating in the market, with a 1-day share price return of 13.84% and a 7-day share price return of 109.40%. The 1-year total shareholder return of 126.27% contrasts with a 5-year total shareholder return of...

Shougang Fushan Resources Group (SEHK:639) issued 2025 earnings guidance, flagging profit of HK$600 million to HK$700 million, compared with HK$1,494 million in 2024, as lower clean coking coal prices weigh on results. See our latest analysis for Shougang Fushan Resources Group. The earnings guidance lands after a strong run for investors, with the latest share price at HK$3.34 and a 1 year total shareholder return of 53.95% alongside a 5 year total shareholder return of 194.16%. This...